World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01391468
Date of registration: 08/07/2011
Primary sponsor: China Medical University Hospital
Public title: Beneficial Effect of Probiotics on Chronic Kidney Disease
Scientific title: Beneficial Effect of Probiotics on Chronic Kidney Disease
Date of first enrolment: August 2011
Target sample size: 180
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01391468
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention  
Countries of recruitment
Taiwan
Contacts
Name:   I-Kuan Wang
Address: 
Telephone: 886-4-22052121
Email: ikwang@seed.net.tw
Affiliation: 
Name:   I-Kuan Wang, MD
Address: 
Telephone: 886-4-22052121
Email: ikwang@seed.net.tw
Affiliation: 
Name:   I-Kuan Wang, M.D.
Address: 
Telephone:
Email:
Affiliation:  China Medical University Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

1. receiving peritoneal dialysis for more than 3 months, at least 18 years of age, and
GFR < 15 ml/min.

2. receiving hemodialysis dialysis for more than 3 months, at least 18 years of age, and
GFR < 15 ml/min.

3. Stage 3 and 4 CKD patients

Exclusion Criteria:

- active infectious conditions within the last 30 days,

- pregnancy for female,

- autoimmune disease e.g. SLE.,

- cardiovascular events before.



Age minimum: 18 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Chronic Kidney Disease
Intervention(s)
Dietary Supplement: Cornstarch
Dietary Supplement: Probiotics
Primary Outcome(s)
CVD occurence [Time Frame: 2 yrs follow-up]
Secondary Outcome(s)
occurrence of peritonitis and improvement of GI symptoms [Time Frame: 2 yrs follow-up]
Secondary ID(s)
DMR-99-IRB-308
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history